Health
FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer – News-Medical.Net
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
The U.S. Food and Drug Administration has request for emergency use authorization a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.
The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want…
-
Noosa News21 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business22 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News18 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business20 hours agoEverything you need to know about the Coles dividend